As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis.
With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD.
The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.
In Collaboration with
Crohn’s & Colitis Congress: A Preview of the “Trends in IBD Care”
Crohn’s & Colitis Congress: A Preview of the “Trends in IBD Care”
Research Takeaways from the Crohn’s & Colitis Congress
Research Takeaways from the Crohn’s & Colitis Congress
Iron Sequestration in Microbiota Biofilms in Treatment for IBD
Iron Sequestration in Microbiota Biofilms in Treatment for IBD
Addressing the Psychosocial Impacts of IBD
Addressing the Psychosocial Impacts of IBD
Diet & Nutrition in the Management of IBD
Diet & Nutrition in the Management of IBD
Emerging 'Bowel-Sparing' Procedures for Crohn's Disease
Emerging 'Bowel-Sparing' Procedures for Crohn's Disease
Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by MR Enterography
Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by MR Enterography
Success of Adalimumab Dose Escalation & De-Escalation in Ulcerative Colitis
Success of Adalimumab Dose Escalation & De-Escalation in Ulcerative Colitis
IBD: A Journey from Parent to Advocate
IBD: A Journey from Parent to Advocate
IBD Patient Management: Professional Education at Your Fingertips
IBD Patient Management: Professional Education at Your Fingertips
What IBD Professionals can Expect from the 2019 Annual Crohn’s & Colitis Congress
What IBD Professionals can Expect from the 2019 Annual Crohn’s & Colitis Congress
Highlights from the Crohn’s & Colitis Foundation Perspectives Series
Highlights from the Crohn’s & Colitis Foundation Perspectives Series
A Message from the President & CEO of Crohn’s & Colitis Foundation
A Message from the President & CEO of Crohn’s & Colitis Foundation
The Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective
The Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective
The Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective
The Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective
